Salah‐Eddin Al‐Batran
Salah‐Eddin Al‐Batran publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Esophageal Cancer Research and Treatment.
- World rank
- #195,736 of 7,710,434 ranked researchers
- Rank in Germany
- #9,948 of 364,343
- Works
- 371
- Citations
- 18k
- Citations per work
- 49.3
What does Salah‐Eddin Al‐Batran research?
Salah‐Eddin Al‐Batran's work is mostly in Medicine (77%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences28877.5%
- Medicine28877.5%
- Everything else6918.6%
- Life Sciences143.9%
- 1Pulmonary and Respiratory Medicine28% of their works
- 2Oncology25% of their works
- 3Surgery15% of their works
- 4Gastroenterology7% of their works
- 5Cancer Research4% of their works
- 6Pathology and Forensic Medicine2% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Esophageal Cancer Research and Treatment
- Gastrointestinal Tumor Research and Treatment
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Metastasis and carcinoma case studies
- Cancer Genomics and Diagnostics
Which keywords describe Salah‐Eddin Al‐Batran's research?
The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Gastric Cancer, Molecular Characterization, Cetuximab, KRAS Mutations, Esophageal Carcinoma and Preoperative Chemoradiotherapy.
- Cancer Genomics
- Lung Tumors
- Immune Checkpoint Blockade
- ALK Inhibitors
- Imatinib Mesylate
- Preoperative Chemoradiotherapy
- KRAS Mutations
- Molecular Characterization
- Endoscopic Resection
- Chemotherapy
- Gastric Cancer
- Cetuximab
- Esophageal Carcinoma
- Targeted Therapy
- Sunitinib
- EGFR Mutations
- PD-1 and PD-L1
- Metastatic Carcinomas
- Mutational Signatures
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Chemotherapy2712 topics
- Endoscopic Resection2452 topics
- Gastric Cancer1721 topic
- Molecular Characterization1721 topic
- Cetuximab991 topic
- KRAS Mutations991 topic
- Esophageal Carcinoma731 topic
- Preoperative Chemoradiotherapy731 topic
- Targeted Therapy662 topics
- Imatinib Mesylate631 topic
- Sunitinib631 topic
- ALK Inhibitors411 topic
- EGFR Mutations411 topic
- Immune Checkpoint Blockade301 topic
- PD-1 and PD-L1301 topic
- Lung Tumors281 topic
- Metastatic Carcinomas281 topic
- Cancer Genomics251 topic
- Mutational Signatures251 topic
Where does Salah‐Eddin Al‐Batran work?
Salah‐Eddin Al‐Batran's main affiliation in the publication record is Krankenhaus Nordwest, Germany.
How many publications and citations does Salah‐Eddin Al‐Batran have?
OpenAlex counts 371 works and 18,299 citations for Salah‐Eddin Al‐Batran, an h-index of 54, ranking #195,736 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Salah‐Eddin Al‐Batran
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Salah‐Eddin Al‐Batran. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.